Corpus gastritis and erosive esophagitis: A report from the Middle East

Indian Journal of Gastroenterology

Volumn 25, Issue 6, 2006, Pages 295-297

  Contractor, Qais Qutub ^a   Ul Haque, Imran ^a   Saka, Hala ^a   Contractor, Tasneem Qais ^a  

^a King Fahd Specialist Hospital Buraidah   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; PREVALENCE; REFLUX ESOPHAGITIS; STOMACH BIOPSY; ADOLESCENT; ADULT; AGED; HELICOBACTER INFECTION; MICROBIOLOGY; MIDDLE AGED; SAUDI ARABIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ESOPHAGITIS, PEPTIC; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; SAUDI ARABIA;

EID: 33947530452     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998;43:327-33.
2. Blaser MJ. Hypothesis: The changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 1999;179:1523-30.
3. El-Serag HB, Sonnenberg A, Jamal MM, Inadomi JM, Crooks LA, Feddersen RM. Corpus gastritis is protective against reflux oesophagitis. Gut 1999;45:181-5.
4. Hamada H, Haruma K, Mihara M, Kamada T, Yoshihara M, Sumii K, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 2000;14:729-35.
5. Koike T, Ohara S, Sekine H, Iijima K, Abe Y, Kato K, et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 2001;49:330-4.
6. Wu JC, Chan FK, Wong SK, Lee YT, Leung WK, Sung JJ, et al. Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis. Aliment Pharmacol Therap 2002;16:545-52.
7. Laine L, Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: A post hoc analysis of eight double blind prospective studies. Am J Gastroenterol 2002;97:2992-7.
8. Wu JC, Sung JJ, Ng EK. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East. Am J Gastroenterol 1999;94:1790-4.
9. al-Moagel MA, Evans DG, Abdulghani ME, Adam E, Evans DJ Jr, Malaty HM, et al. Prevalence of Helicobacter (formerly Campylobacter) pylori infection in Saudi Arabia, and comparison of those with and without upper gastrointestinal symptoms. Am J Gastroenterol 1990; 85:944-8.
10. Ollyo JB, Lang F, Fontolliet C, Monnier P. Savary-Miller's new endoscopic grading of reflux esophagitis: a simple, reproducible, logical, complete and useful classification. Gastroenterology 1990;98:A100.
11. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis, the updated Sydney system. Am J Surg Pathol 1996;20:1161-81.
12. El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KEL. Helicobacter pylori infection in patients with duodenal ulcer disease. Gastroenterology 1995;109:681-91.
13. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15-24.
14. Labenz J, Blum AL, Bayerdortfer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in duodenal ulcer patients may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
15. Queiroz DMM, Rocha GA, Oliveira CA, Rocha AMC, Santos A, Cabral MMDA, et al. Role of corpus gastritis and cagA-positive Helicobacter pylori infection in reflux esophagitis. J Clin Microbiol 2002;40:2849-53.
16. Queiroz DMM, Guerra JB, Rocha GA, Rocha AMC, Santos A, De Oliveira AG, et al. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology 2004;127:73-9.
17. Barlow WJ, Orlando RC. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology 2005;128:771-8.
18. Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, et al. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 2004;53:12-20.
19. Koike T, Ohara S, Sekine H, Iijima K, Kato K, Toyota T, et al. Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux disease. Aliment Pharmacol Ther 2001;15:813-20.
20. Sharma VK, Crowell MD, Howden CW. Infection with H. pylori or cagA+ H. pylori is protective against Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC): a meta-analysis (Abstract). Gastroenterology 2004;126(Suppl 2):A87.